Viewing Study NCT04693533


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-22 @ 4:52 PM
Study NCT ID: NCT04693533
Status: RECRUITING
Last Update Posted: 2025-01-22
First Post: 2020-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fremanezumab, Migraine and Sleep
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module